TMDX - TransMedics Group, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Andover,
United States
Type: Equity
TMDX price evolution
TMDX
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $363.25 | $350.72 | $395.31 | $427.61 |
| Short term investments | ||||
| Net receivables | $81.16 | $81.94 | $63.58 | $60.65 |
| Inventory | $48.67 | $48.54 | $44.23 | $39.37 |
| Total current assets | $509.26 | $488.31 | $510.65 | $536.72 |
| Long term investments | ||||
| Property, plant & equipment | $234.93 | $220.65 | $180.49 | $137.87 |
| Goodwill & intangible assets | $13.8 | $14.29 | $14.34 | $14.08 |
| Total noncurrent assets | $249.31 | $235.53 | $195.39 | $152.5 |
| Total investments | ||||
| Total assets | $758.58 | $723.83 | $706.05 | $689.23 |
| Current liabilities | ||||
| Accounts payable | $13.03 | $9.22 | $12.72 | $12.84 |
| Deferred revenue | $1.45 | $2.06 | $1.96 | $2.63 |
| Short long term debt | $2.14 | $2.09 | $2.04 | $1.99 |
| Total current liabilities | $54.33 | $50.22 | $54.93 | $49.1 |
| Long term debt | $514.35 | $514.14 | $513.91 | $513.67 |
| Total noncurrent liabilities | $514.35 | $514.14 | $513.91 | $513.67 |
| Total debt | $516.49 | $516.22 | $515.95 | $515.65 |
| Total liabilities | $568.68 | $564.36 | $568.85 | $562.77 |
| Shareholders' equity | ||||
| Retained earnings | -$479.31 | -$491.51 | -$503.7 | -$507.74 |
| Other shareholder equity | -$0.24 | -$0.18 | -$0.2 | -$0.26 |
| Total shareholder equity | $189.89 | $159.47 | $137.2 | $126.46 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $395.31 | $201.68 | $26.08 | $25.08 |
| Short term investments | $66.87 | $101.06 | ||
| Net receivables | $63.58 | $27.61 | $5.93 | $6.86 |
| Inventory | $44.23 | $20.61 | $14.86 | $11.93 |
| Total current assets | $510.65 | $252.29 | $118.7 | $146.77 |
| Long term investments | ||||
| Property, plant & equipment | $180.49 | $24.35 | $15.69 | $4.75 |
| Goodwill & intangible assets | $14.34 | |||
| Total noncurrent assets | $195.39 | $24.85 | $16.19 | $5.26 |
| Total investments | $66.87 | $101.06 | ||
| Total assets | $706.05 | $277.15 | $134.89 | $152.03 |
| Current liabilities | ||||
| Accounts payable | $12.72 | $3.34 | $6.65 | $1.21 |
| Deferred revenue | $1.96 | $0.24 | $0.25 | $0.26 |
| Short long term debt | $2.04 | $1.44 | ||
| Total current liabilities | $54.93 | $23.66 | $23.24 | $11.88 |
| Long term debt | $513.91 | $66.11 | $43.8 | $34.66 |
| Total noncurrent liabilities | $513.91 | $66.11 | $43.8 | $36.26 |
| Total debt | $515.95 | $67.56 | $43.8 | $34.66 |
| Total liabilities | $568.85 | $89.77 | $67.04 | $48.13 |
| Shareholders' equity | ||||
| Retained earnings | -$503.7 | -$478.68 | -$442.45 | -$398.23 |
| Other shareholder equity | -$0.2 | -$0.23 | -$0.19 | -$0.1 |
| Total shareholder equity | $137.2 | $187.38 | $67.85 | $103.89 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $114.31 | $96.85 | $81.17 | $66.43 |
| Cost of revenue | $45.04 | $36.89 | $33.25 | $25.77 |
| Gross Profit | $69.26 | $59.96 | $47.92 | $40.66 |
| Operating activities | ||||
| Research & development | $13.86 | $11.38 | $10.76 | $11.13 |
| Selling, general & administrative | $42.9 | $36.16 | $34.56 | $30.65 |
| Total operating expenses | $56.75 | $47.54 | $45.32 | $69 |
| Operating income | $12.51 | $12.42 | $2.6 | -$28.34 |
| Income from continuing operations | ||||
| EBIT | $15.78 | $15.99 | $7.47 | -$23.34 |
| Income tax expense | -$0.04 | $0.2 | -$0.17 | -$1.51 |
| Interest expense | $3.62 | $3.6 | $3.6 | $3.59 |
| Net income | ||||
| Net income | $12.19 | $12.2 | $4.03 | -$25.42 |
| Income (for common shares) | $12.19 | $12.2 | $4.03 | -$25.42 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $241.62 | $93.46 | $30.26 | $25.64 |
| Cost of revenue | $87.53 | $28.19 | $9.1 | $9 |
| Gross Profit | $154.09 | $65.27 | $21.16 | $16.64 |
| Operating activities | ||||
| Research & development | $36.05 | $26.81 | $22.3 | $18.83 |
| Selling, general & administrative | $119.55 | $69.9 | $38.28 | $24.19 |
| Total operating expenses | $182.82 | $96.71 | $60.59 | $43.02 |
| Operating income | -$28.73 | -$31.44 | -$39.43 | -$26.38 |
| Income from continuing operations | ||||
| EBIT | -$15.88 | -$32.44 | -$40.3 | -$24.73 |
| Income tax expense | -$1.64 | $0.07 | $0.04 | $0.03 |
| Interest expense | $10.79 | $3.73 | $3.87 | $3.98 |
| Net income | ||||
| Net income | -$25.03 | -$36.23 | -$44.22 | -$28.75 |
| Income (for common shares) | -$25.03 | -$36.23 | -$44.22 | -$28.75 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $12.19 | $12.2 | $4.03 | -$25.42 |
| Operating activities | ||||
| Depreciation | $4.93 | $4.62 | $3.92 | $2.2 |
| Business acquisitions & disposals | -$42.11 | |||
| Stock-based compensation | $7.64 | $6.87 | $5.72 | $5.19 |
| Total cash flows from operations | $25.72 | -$3.44 | $8.3 | -$6.87 |
| Investing activities | ||||
| Capital expenditures | -$23.76 | -$44.17 | -$41.82 | -$107.72 |
| Investments | ||||
| Total cash flows from investing | -$23.76 | -$44.17 | -$41.82 | -$149.83 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.64 | $3.19 | $0.92 | $1.52 |
| Net borrowings | ||||
| Total cash flows from financing | $10.64 | $3.19 | $0.92 | $1.52 |
| Effect of exchange rate | -$0.06 | -$0.17 | $0.29 | -$0.18 |
| Change in cash and equivalents | $12.53 | -$44.59 | -$32.3 | -$155.35 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$25.03 | -$36.23 | -$44.22 | -$28.75 |
| Operating activities | ||||
| Depreciation | $9.22 | $4.2 | $2.65 | $1.58 |
| Business acquisitions & disposals | -$42.11 | |||
| Stock-based compensation | $19.79 | $10.32 | $6.88 | $2.41 |
| Total cash flows from operations | -$13.03 | -$45.82 | -$28.86 | -$30.27 |
| Investing activities | ||||
| Capital expenditures | -$151.85 | -$11.91 | -$3.52 | -$0.46 |
| Investments | $66.42 | $32.79 | -$41.14 | |
| Total cash flows from investing | -$193.95 | $54.51 | $29.27 | -$41.6 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.11 | $145.47 | $1.39 | $76.25 |
| Net borrowings | $393.31 | $22.46 | ||
| Total cash flows from financing | $400.42 | $167.93 | $1.39 | $75.55 |
| Effect of exchange rate | $0.19 | -$1.02 | -$0.8 | $0.8 |
| Change in cash and equivalents | $193.63 | $175.6 | $1 | $4.49 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $358.76M |
|---|---|
| EBITDA | $31.56M |
| EBIT | $15.90M |
| Net Income | $3.00M |
| Revenue Q/Q | 117.87% |
| Revenue Y/Y | 137.47% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 0.42% |
| ROE | 1.96% |
| Debt/Equity | 4.15 |
|---|---|
| Net debt/EBITDA | 6.51 |
| Current ratio | 9.37 |
| Quick ratio | 8.48 |